156 related articles for article (PubMed ID: 3731919)
1. Josamycin: interpretation of inhibition zones with the Bauer-Kirby agar disk diffusion test as compared with erythromycin.
Karthein J; Spohr M; Traub WH
Chemotherapy; 1986; 32(4):336-43. PubMed ID: 3731919
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
Soussy CJ; Leclercq R; Duval J
Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
[TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
Soussy CJ; Chanal M; Kitzis MD; Duval J; Cluzel R; Acar JF
Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
Westerman EL; Williams TW; Moreland N
Antimicrob Agents Chemother; 1976 Jun; 9(6):988-93. PubMed ID: 7189
[TBL] [Abstract][Full Text] [Related]
5. Tentative inhibition zone criteria (Bauer-Kirby agar disk diffusion method) for rifampin against staphylococci.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1987; 33(6):412-8. PubMed ID: 3428008
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of YM133, a new semisynthesized macrolide.
Terasawa T; Watanabe M; Okubo T; Mitsuhashi S
Antimicrob Agents Chemother; 1991 Jul; 35(7):1370-5. PubMed ID: 1929295
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility studies with josamycin and erythromycin.
Strausbaugh LJ; Dilworth JA; Gwaltney JM; Sande MA
Antimicrob Agents Chemother; 1976 Mar; 9(3):546-8. PubMed ID: 4012
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of A-56268.
Sefton AM; Maskell JP; Yong FJ; Chi SJ; Williams JD
Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):798-802. PubMed ID: 2975218
[TBL] [Abstract][Full Text] [Related]
9. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
King A; Phillips I
Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
[TBL] [Abstract][Full Text] [Related]
10. Comparative in-vitro activities of A-56268 (TE-031) and erythromycin against 306 clinical isolates.
Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV; Shayegani M
J Antimicrob Chemother; 1988 May; 21(5):565-70. PubMed ID: 2968968
[TBL] [Abstract][Full Text] [Related]
11. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
Drabu YJ; Mehtar S; Blakemore PH
Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci.
Hamilton-Miller JM
J Antimicrob Chemother; 1992 Feb; 29(2):141-7. PubMed ID: 1506329
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of josamycin against erythromycin-resistant staphylococci as compared to roxythromycin and clarithromycin.
Guggenbichler JP; Georgopoulos A; Scharrer P; Kobilansky C; Mühlbacher J; Georgopoulos M; Dierich MP
Infection; 1993; 21(4):259-61. PubMed ID: 8225634
[TBL] [Abstract][Full Text] [Related]
14. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
Dibb WL; Ragnhildstveit E
NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
[TBL] [Abstract][Full Text] [Related]
15. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
[TBL] [Abstract][Full Text] [Related]
16. Agar disk diffusion (Bauer-Kirby) tests with various fastidious and nonfastidious reference (ATCC) strains: comparison of several agar media.
Traub WH; Leonhard B
Chemotherapy; 1994; 40(6):374-83. PubMed ID: 7842820
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
Rolston KV; LeBlanc B; Ho DH
J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
[TBL] [Abstract][Full Text] [Related]
18. [The in vitro effects of josamycin on various strains of bacteria].
Milosovic P; Simkovicová M
Bratisl Lek Listy; 1989 Dec; 90(12):907-10. PubMed ID: 2627653
[TBL] [Abstract][Full Text] [Related]
19. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
Traub WH; Leonhard B
Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of MC-352, a new 16-membered macrolide.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1992 Aug; 36(8):1699-702. PubMed ID: 1416853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
